| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | PAYP | Japan | $19.91 | $0.00 | Buy | 9 | 2026 |
#2 | LYFT | United States | $13.06 | $6,316,261,000.00 | Buy | 29 | 2019 |
#3 | TOST | United States | $23.09 | $6,153,000,000.00 | Buy | 22 | 2021 |
#4 | SIG | Bermuda | $78.77 | $6,247,100,000.00 | Buy | 7 | 1997 |
#5 | CARG | United States | $29.92 | $316,861,000.00 | Buy | 11 | 2017 |
#6 | NFG | United States | $81.79 | $2,277,541,000.00 | Buy | 4 | 1997 |
#7 | WAY | United States | $18.70 | $1,099,278,000.00 | Strong Buy | 17 | 2023 |
#8 | TREE | United States | $35.95 | $1,117,324,000.00 | Strong Buy | 4 | 2008 |
#9 | CVNA | United States | $69.34 | $20,322,000,000.00 | Buy | 24 | 2017 |
#10 | GMED | United States | $77.05 | $2,938,931,000.00 | Buy | 14 | 2012 |
#11 | TMDX | United States | $61.90 | $605,494,000.00 | Buy | 9 | 2019 |
#12 | SHAK | United States | $62.13 | $1,445,306,000.00 | Buy | 26 | 2014 |
#13 | VRRM | United States | $13.24 | $132,969,000.00 | Buy | 5 | 2016 |
#14 | DAN | United States | $34.59 | $7,500,000,000.00 | Buy | 5 | 1998 |
#15 | EYE | United States | $17.55 | $1,987,488,000.00 | Strong Buy | 9 | 2017 |
#16 | FRPT | United States | $49.13 | $1,102,015,000.00 | Buy | 17 | 2014 |
#17 | AORT | United States | $22.97 | $298,836,000.00 | Strong Buy | 5 | 1996 |
#18 | AMRX | United States | $12.22 | $0.00 | Strong Buy | 5 | 2018 |
#19 | CALX | United States | $40.27 | $510,367,000.00 | Strong Buy | 5 | 2009 |
#20 | BXMT | United States | $18.48 | $0.00 | Buy | 5 | 1998 |
#21 | APEI | United States | $54.07 | $198,174,000.00 | Strong Buy | 7 | 2007 |
#22 | SWX | United States | $89.20 | $5,433,972,000.00 | Strong Buy | 5 | 2017 |
#23 | NCNO | United States | $14.68 | $594,781,000.00 | Buy | 16 | 2022 |
#24 | NVST | United States | $23.80 | $2,566,500,000.00 | Buy | 13 | 2019 |
#25 | ALHC | United States | $16.62 | $3,948,719,000.00 | Buy | 8 | 2021 |
#26 | NMRK | United States | $14.92 | $3,294,024,000.00 | Buy | 5 | 2017 |
#27 | OMER | United States | $13.31 | $29,868,000.00 | Strong Buy | 5 | 2008 |
#28 | WWW | United States | $15.03 | $1,874,300,000.00 | Buy | 10 | 2002 |
#29 | STOK | United States | $31.34 | $184,420,000.00 | Strong Buy | 10 | 2019 |
#30 | PEGA | United States | $33.43 | $682,695,000.00 | Buy | 12 | 1996 |
#31 | CLMT | United States | $31.32 | $4,137,100,000.00 | Strong Buy | 5 | 2024 |
#32 | AMLX | United States | $13.91 | $380,786,000.00 | Strong Buy | 9 | 2021 |
#33 | IDYA | United States | $28.88 | $218,710,000.00 | Strong Buy | 16 | 2019 |
#34 | AZTA | United States | $16.87 | $593,821,000.00 | Strong Buy | 5 | 1996 |
#35 | CSV | United States | $43.53 | $417,440,000.00 | Strong Buy | 4 | 1996 |
#36 | DOCS | United States | $18.04 | $570,399,000.00 | Buy | 22 | 2021 |
#37 | WK | United States | $45.42 | $884,568,000.00 | Strong Buy | 10 | 2014 |
#38 | CRVS | United States | $13.65 | $0.00 | Strong Buy | 6 | 2016 |
#39 | USFD | United States | $84.19 | $39,424,000,000.00 | Buy | 11 | 2016 |
#40 | ACM | United States | $70.99 | $16,139,622,000.00 | Strong Buy | 10 | 2007 |
#41 | BFAM | United States | $69.19 | $1,903,182,000.00 | Buy | 7 | 2012 |
#42 | W | United States | $61.28 | $0.00 | Buy | 28 | 2014 |
#43 | CRTO | France | $16.03 | $2,296,692,000.00 | Strong Buy | 10 | 2013 |
#44 | ERAS | United States | $10.44 | $0.00 | Strong Buy | 12 | 2021 |
#45 | ZYME | United States | $23.91 | $105,965,000.00 | Strong Buy | 11 | 2022 |
#46 | PPL | United States | $35.76 | $9,042,000,000.00 | Buy | 13 | 2007 |
#47 | SBH | United States | $11.88 | $3,701,424,000.00 | Buy | 6 | 2006 |
#48 | RLAY | United States | $12.79 | $15,355,000.00 | Strong Buy | 10 | 2020 |
#49 | IMAX | Canada | $33.95 | $410,212,000.00 | Strong Buy | 10 | 1997 |
#50 | LMAT | United States | $99.54 | $249,602,000.00 | Buy | 5 | 2006 |
The FinQuota filters have identified what they believe to be the "Best Stocks Under $100 to Buy (May 15, 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.